Got $5,000? Invest It in Any of These 6 Coronavirus Vaccine Stocks
The biotech sector has been a significant contributor to this year's market recovery, thanks to its rapid advancement of several experimental coronavirus vaccines to clinical trials. A successful vaccine would effectively end the coronavirus pandemic, save lives worldwide, and allow governments to reopen their economies safely.
Biotech stocks have no intrinsic value without their science -- so an interested investor's best bet is to buy coronavirus vaccine companies that are publishing good immunization data on their candidates. Today, let's look at six stocks that fit this category, and why any company on this list is a solid option for a $5,000 investment.
Image source: Getty Images.
Source Fool.com
